These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35588865)

  • 1. Growth differentiation factor-15 overexpression promotes cell proliferation and predicts poor prognosis in cerebral lower-grade gliomas correlated with hypoxia and glycolysis signature.
    Wang Y; Chen J; Chen C; Peng H; Lin X; Zhao Q; Chen S; Wang X
    Life Sci; 2022 Aug; 302():120645. PubMed ID: 35588865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.
    Zhang L; He L; Lugano R; Roodakker K; Bergqvist M; Smits A; Dimberg A
    Neuro Oncol; 2018 Oct; 20(11):1505-1516. PubMed ID: 29846705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
    Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
    Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas
    Huang X; Zhang F; He D; Ji X; Gao J; Liu W; Wang Y; Liu Q; Xin T
    Front Oncol; 2021; 11():646060. PubMed ID: 34094933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
    Jiang H; Sun Z; Li F; Chen Q
    Front Immunol; 2022; 13():983569. PubMed ID: 36405708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of lysyl oxidase is associated with poor prognosis and response to therapy of patients with lower grade gliomas.
    Huang SP; Chiou J; Jan YH; Lai TC; Yu YL; Hsiao M; Lin YF
    Biochem Biophys Res Commun; 2018 Jun; 501(3):619-627. PubMed ID: 29729273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
    Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y
    Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma.
    Xiao F; Jie X; Zhou X; Guo Y; Sun GF; Lin L; Hu GW; Huang K; Guo H
    Biosci Rep; 2023 May; 43(5):. PubMed ID: 37083601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
    Li Y; Feng Y; Luo F; Peng G; Li Y
    Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foreboding lncRNA markers of low-grade gliomas dependent on metabolism.
    Lu Z; Feng Y
    Medicine (Baltimore); 2022 Nov; 101(44):e31302. PubMed ID: 36343057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.